On December 18th 2019, UL, the global leader in safety expertise, officially awarded Zhongke Meiling Cryogenics Technology Co., Ltd. ("Meiling Biomedical") the Witness Test Program (WTDP) Lab certificate for supporting greater China's manufacturer's initiative for faster global market access. This is the first certificate to be awarded in the field of medical cryogenic devices.
The WTDP collaborative laboratory program reflects UL's commitment to providing high-quality, customized testing and certification service to domestic medical device manufacturers and their continued support of for local manufacturers to enhance product competitiveness and accelerate access to global market.
Zhongke Meiling Cryogenics Technology Co., Ltd. (Meiling Biomedical) is one of the leading domestic medical cryogenic devices manufacturers and has been devoted to technology innovation, quality improvement and customer centralization since it's foundation. With more than 10-years development, Meiling Biomedical has developed from single-product mode to a diversified-product group.
As the leader in the field of third-party testing certification and standard development, UL has been committed to healthcare industry since 1990 and has successfully helped hundreds of domestic medical device manufacturers achieve safety certification and access to overseas markets.
In the past 10 years' of industry development and transformation, UL insists on innovation and has grown from a traditional single testing and certification operation to a full life-cycle integration business solution. UL's services cover research and design, testing and certification, market access, quality assurance, and post-market surveillance.
The cooperation between Meiling Biomedical and UL will further strengthen the in-depth relationship between the two parties through product safety testing, market registration and technical exchanges. Under WTDP certificate, Meiling Biomedical can make full use of its fully equipped laboratories and can conduct product testing programs under the on-site witness of UL technical engineers. This will significantly benefit the traditional testing period and accelerate the time to global market access.
Meiling Biomedical Deputy General Manager, Mr. Hu XiaoZong:
"In recent years, Meiling Biomedical has upgraded and transformed, having been developed to be the leader of medical cryogenic device industry. Under the strategy of overseas market deployment, Meiling Biomedical has expanded its overseas business rapidly. UL's full-cycle, one-stop service has provided timely, professional and active technical support, covering product development, testing, certification, and training. The WTDP collaboration will be the brand-new milestone between Meiling Biomedical and UL, and Meiling Biomedical is greatly looking forward to much closer cooperation in the near future."
UL Life and Health Sciences Division Asia Pacific General Manager, Gary Gu:
"Since UL Life and Health Sciences Division entered China market in 2000, UL has been devoted to supporting domestic medical device manufacturers to achieve fast access to global market. UL's one-stop solution will provide efficient, convenient and globally-competitive value-added services to local medical device manufacturers, covering not only testing and certification services, but also the integrated global market access solution from product development to testing and from market registration to post-market surveillance.
The WTDP collaboration with Meiling Biomedical represents that UL will not only provide more professional and more customized technical support, but also will provide full life-cycle support to significantly enhance Meiling's global competitiveness and expand overseas market."
UL will continue to provide high-quality testing and certification service to domestic and overseas medical device manufacturers, supporting the acceleration of global market expansion.
About UL Life and Health Sciences
The UL Life & Health Sciences division is dedicated to healthcare industry innovation by helping clients with their biggest challenges in regulatory management, market access, and connected device risk i.e. safety, security, usability, and interoperability. We ensure that medical devices are safe to deploy and use in an increasingly patient-centric and connected environment.
UL brings decades of the most advanced technical, regulatory and clinical expertise to solve the toughest challenges in the market with the goal of improving access to advanced safe healthcare around the world.
About Zhongke Meiling Cryogenics Co., Ltd.
As one of the leading cryogenics device manufacturers, Zhongke Meiling Cryogenics Co., Ltd.(Meiling Biomedical) engages in life science, family health and cold chain solutions, including products such as lab / medical refrigerator and freezer, ultra-low temperature freezer, as well as providing solutions including MIBS intelligent biobank, wireless intelligent temperature monitoring, cold-chain storage, blood security solution, and CO2/liquid nitrogen backup system. Meling's business spans more than 50 countries including: Europe, America, Asia, Latin America and Africa.